RU95117134A - DERIVATIVE MORPHOLINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PHARMACEUTICAL COMPOSITION ON ITS BASIS - Google Patents
DERIVATIVE MORPHOLINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PHARMACEUTICAL COMPOSITION ON ITS BASISInfo
- Publication number
- RU95117134A RU95117134A RU95117134/04A RU95117134A RU95117134A RU 95117134 A RU95117134 A RU 95117134A RU 95117134/04 A RU95117134/04 A RU 95117134/04A RU 95117134 A RU95117134 A RU 95117134A RU 95117134 A RU95117134 A RU 95117134A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- morpholine
- pharmaceutical composition
- indanyl
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims 9
- 239000011780 sodium chloride Substances 0.000 title claims 9
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 title claims 3
- 229940113083 morpholine Drugs 0.000 title claims 3
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 4
- HTODIQZHVCHVGM-UHFFFAOYSA-N 2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine Chemical compound C1=2CCCC=2C(F)=CC=C1OCC1CNCCO1 HTODIQZHVCHVGM-UHFFFAOYSA-N 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 150000002780 morpholines Chemical class 0.000 claims 2
- 230000003287 optical Effects 0.000 claims 2
- -1 7-fluoro-4-indanyl Chemical group 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000003042 antagnostic Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N fumaric acid Chemical compound OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
Claims (10)
где R1 и R3, которые могут быть одинаковыми или различными, каждый, обозначают атом водорода или низшую алкильную группу;
R2 обозначает атом галогена;
пунктирная линия обозначает необязательную двойную связь,
или его фармацевтически приемлемая соль.1. Derived morpholine represented by formula I
where R 1 and R 3 , which may be the same or different, each represent a hydrogen atom or a lower alkyl group;
R 2 represents a halogen atom;
the dotted line indicates an optional double bond,
or its pharmaceutically acceptable salt.
где R1 и R3, которые могут быть одинаковыми или различными, каждый, обозначают атом водорода или низшую алкильную группу;
R2 обозначает атом галогена;
пунктирная линия обозначает необязательную двойную связь,
или его фармацевтически приемлемая соль.2. The levorotatory optical isomer of a morpholine derivative represented by formula I
where R 1 and R 3 , which may be the same or different, each represent a hydrogen atom or a lower alkyl group;
R 2 represents a halogen atom;
the dotted line indicates an optional double bond,
or its pharmaceutically acceptable salt.
где R1 и R3, которые могут быть одинаковыми или различными, каждый, обозначают атом водорода или низшую алкильную группу;
R2 обозначает атом галогена,
или его фармацевтически приемлемая соль.3. Derived morpholine represented by formula II
where R 1 and R 3 , which may be the same or different, each represent a hydrogen atom or a lower alkyl group;
R 2 denotes a halogen atom,
or its pharmaceutically acceptable salt.
где R1 и R3, которые могут быть одинаковыми или различными, каждый, обозначают атом водорода или низшую алкильную группу;
R2 обозначает атом галогена,
или его фармацевтически приемлемая соль.4. The levorotatory optical isomer of a morpholine derivative represented by formula II
where R 1 and R 3 , which may be the same or different, each represent a hydrogen atom or a lower alkyl group;
R 2 denotes a halogen atom,
or its pharmaceutically acceptable salt.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4569193 | 1993-02-10 | ||
| JP5-45691 | 1993-02-10 | ||
| JP5-240147 | 1993-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU95117134A true RU95117134A (en) | 1997-09-27 |
| RU2123496C1 RU2123496C1 (en) | 1998-12-20 |
Family
ID=12726414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU95117134A RU2123496C1 (en) | 1993-02-10 | 1994-02-08 | Morpholine derivative or its pharmaceutically acceptable salt and pharmaceutical composition based on thereof |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2123496C1 (en) |
-
1994
- 1994-02-08 RU RU95117134A patent/RU2123496C1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950017957A (en) | Preparation and intermediates of 3, 4, 4-trisubstituted-piperidinyl-N-alkylcarboxylates | |
| KR900015721A (en) | New Methods and Compounds | |
| EP0323757A3 (en) | Alkylaminopyrimidine derivative, process for producing the same, and insecticide, acaricide and fungicide containing the same as active ingredient | |
| DK269083D0 (en) | HYDROXYALKYNYL-AZOLYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES | |
| EA200200489A1 (en) | NEW COMPOUNDS OF BENZOTHIADIAZINE, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
| DK55683A (en) | FUNGICIDE INDANYL BENZAMIDES AND PROCEDURES FOR PREPARING IT | |
| NO834884L (en) | PROCEDURE FOR PREPARING PHARMACOLOGICAL ACTIVE NITROALIFATIC COMPOUNDS | |
| ATE48994T1 (en) | BENZIMIDAZOLE DERIVATIVE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION. | |
| DE3668888D1 (en) | AN IMIDAZOLID INTRION DERIVATIVE OR A PHARMACEUTICAL COMPOSITION CONTAINING ITS PHARMACEUTICAL ACCEPTABLE SALTS. | |
| RU95117134A (en) | DERIVATIVE MORPHOLINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
| CA2118425A1 (en) | Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof | |
| MX9206930A (en) | NEW COMPOUNDS | |
| KR890008148A (en) | New Sepharoseporin Compounds and Antibacterials | |
| DK0420224T3 (en) | Anthihepatopathic remedy | |
| MX9101066A (en) | FUNGICIDE DERIVATIVES OF ACID 3,3, -BISTIOALQUIL-2-PIRIDIL-ACRILICO | |
| KR900701763A (en) | 1-amino-5-halogenouracil, preparation method thereof, and central nervous system inhibitor containing the compound as an active ingredient | |
| EP0364943A3 (en) | Benzoheterocyclic compounds | |
| EP0503079A4 (en) | Pyridazinone-substituted ethynylphenyl derivative and remedy for circulatory organ disease containing the same as active ingredient | |
| BR8305266A (en) | ACTIVE COMPOUND AS FUNGICIDE AND PREPARATION PROCESS; FUNGICIDE COMPOSITION AND METHOD FOR COMBATING FUNGI IN A CERTAIN LOCATION | |
| DK0556813T3 (en) | Amphoteric tricyclic compounds such as antihistamine and antiallergic agents | |
| JPS6466116A (en) | Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs | |
| KR850005228A (en) | Aminoalkanosephosphonic acid and its derivatives as fungicides | |
| ES547604A0 (en) | A PROCEDURE FOR PREPARING 2-PIRIDIN-TIOL DERIVATIVES | |
| FR2572074B1 (en) | THIADIAZOLE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| KR920002594A (en) | 5-isothiazolamine derivative |